Improving communication between organizations as a patient advocate

Felice Bombaci from the AIL patient group for chronic myeloid leukemia (CML), Rome, Italy, works with AIL, a patient advocacy organization, as well as a variety of patient groups and associations to improve patient disease understanding and support across a variety of blood diseases. In this video, recorded at the 1st European Myeloma Network (EMN) Meeting 2018, held in Turin, Italy, he emphasizes the importance of networking as a patient advocate. He discusses how collaboration between patients, physicians, pharmaceutical corporations, scientific organizations, and policy makers, is essential for improving treatment and support options for patients with any disease.